...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >An experimental study to investigate the effects of venlafaxine and escitalopram on anticonvulsant activity of conventional antiepileptic drugs in mice
【24h】

An experimental study to investigate the effects of venlafaxine and escitalopram on anticonvulsant activity of conventional antiepileptic drugs in mice

机译:研究文拉法辛和艾司西酞普兰对小鼠常规抗癫痫药抗惊厥活性的影响的实验研究

获取原文
           

摘要

Background: Depression is a common psychiatric comorbidity in patients with epilepsy which remains often untreated, due to concern of antidepressant induced seizures. The safety status of selective serotonin reuptake inhibitors (SSRIs) in epileptics is controversial. Methods: Phase I acute effect of venlafaxine and escitalopram on the seizure threshold was studied. Phase II, the acute effects of test ADDs on the effective dose of AEDs viz valproate, phenobarbitone and phenytoin were studied in maximal electroshock (MES). Phase III- same study design as in phase II except that AEDs and ADDs were administered daily for 28 days. Results: Venlafaxine raised the electroconvulsive threshold in a dose dependant manner in phase I, however it was significant at a dose of 25mg/kg. In phase II, a significant reduction in ED50 of valproate was observed when it was co-administered with venlafaxine at dose of 12.5 and 25mg/kg, whereas ED50 of phenobarbitone was significantly reduced at a dose of 25mg/kg. Chronic administration of venlafaxine at 12.5mg/kg daily reduced ED50 of valproate. At 25mg/kg daily ED50 of all the three studied AEDs was reduced, Escitalopram 8mg/kg significantly raised the electroconvulsive threshold value in phase 1, Escitalopram administered in the dose of 8mg/kg reduced the ed50 value of valproate. Escitalopram given in dose of 4 and 8mg/kg reduced the ED50 value of valproate. Conclusions: From this finding, it may be concluded that venlafaxine and escitalopram administered either alone or in combination with AEDs acutely or chronically, exhibit anticonvulsant action.
机译:背景:抑郁症是癫痫患者常见的精神病合并症,由于担心会因抗抑郁药引起的癫痫发作而常常未得到治疗。选择性5-羟色胺再摄取抑制剂(SSRIs)在癫痫患者中的安全性状况存在争议。方法:研究文拉法辛和艾司西酞普兰对癫痫发作阈值的一期急性作用。在最大电击(MES)中研究了阶段II,测试ADD对AED有效剂量即丙戊酸,苯巴比妥和苯妥英钠的急性作用。 III期-与II期相同的研究设计,除了AED和ADD每天给药28天。结果:文拉法辛在第一阶段以剂量依赖性方式提高了电惊厥阈值,但在25mg / kg剂量时显着。在阶段II中,当与venlafaxine分别以12.5和25mg / kg的剂量合用时,观察到丙戊酸盐的ED50显着降低,而苯巴比妥的ED50在25mg / kg的剂量下显着降低。每天以12.5mg / kg的剂量长期服用文拉法辛可降低丙戊酸盐的ED50。在所有研究的三种AED中,当每日ED50降低25mg / kg时,艾司西酞普兰8mg / kg显着提高了第1阶段的电惊厥阈值,以8mg / kg的剂量服用艾司西酞普兰降低了丙戊酸盐ed50值。依他普仑的剂量为4和8mg / kg会降低丙戊酸盐的ED50值。结论:从这个发现,可以得出结论,文拉法辛和依西酞普兰单独或与急性或慢性AED联合给药,均表现出抗惊厥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号